BOULDER, Colo.--(BUSINESS WIRE)-- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the UBS Global Life Sciences Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: UBS Global Life Sciences Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Monday, September 19, 2011
Time: 10:00 a.m. Eastern Time
Location: The Grand Hyatt New York, NY
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to www.arraybiopharma.com.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
KEYWORDS: United States North America Colorado New York
INDUSTRY KEYWORDS: Health Biotechnology Oncology Pharmaceutical